Makes over-the-counter drugs and infant formula products.
Jun 2026Revenue $4.14B/yrExpenses $5.71B/yr
No trend
Figures by year
When will PERRIGO be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $4.14B and expenses $5.71B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $4.25B | $5.38B | −$1.12B |
| Dec 2024 | $4.37B | $4.26B | $113M |
| Dec 2023 | $4.66B | $4.50B | $152M |
| Dec 2022 | $4.45B | $4.37B | $78.9M |
| Dec 2021 | $4.14B | $3.73B | $410M |
| Dec 2020 | $4.09B | $3.82B | $265M |
| Dec 2019 | $3.87B | $3.70B | $175M |
| Dec 2018 | $4.73B | $4.50B | $237M |
| Dec 2017 | $4.95B | $4.35B | $598M |
| Dec 2016 | $5.28B | $7.28B | −$2.00B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.